Cargando…
Correction: Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs
Autores principales: | Chen, Feng, Wang, Huihui, Zhu, Jiayu, Zhao, Rui, Xue, Peng, Zhang, Qiang, Nelson, M Bud, Qu, Weidong, Feng, Bo, Pi, Jingbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738118/ https://www.ncbi.nlm.nih.gov/pubmed/31350527 http://dx.doi.org/10.1038/s41416-019-0527-1 |
Ejemplares similares
-
Camptothecin suppresses NRF2–ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs
por: Chen, Feng, et al.
Publicado: (2017) -
Camptothecin improves sorafenib sensitivity by inhibiting Nrf2‑ARE pathway in hepatocellular carcinoma
por: Sun, Liwei, et al.
Publicado: (2023) -
Camptothecin Sensitizes Hepatocellular Carcinoma Cells to Sorafenib- Induced Ferroptosis Via Suppression of Nrf2
por: Elkateb, Ahmed S., et al.
Publicado: (2023) -
c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis
por: Arango, D, et al.
Publicado: (2003) -
Nrf2 Down-Regulation by Camptothecin Favors Inhibiting Invasion, Metastasis and Angiogenesis in Hepatocellular Carcinoma
por: Liu, Qian, et al.
Publicado: (2021)